Sequenom Gets Final Approval for Class Action Settlement | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom today said that the US District Court for the Southern District of California has approved the settlement reached in a class action suit brought by shareholders of the firm.

Under the settlement, Sequenom agreed to pay shareholders $14 million, and it agreed to issue to the plaintiffs a number of shares of Sequenom common stock.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.